The role of clusterin in attenuation of inflammation and reverse cholesterol transfer makes this molecule a potential candidate as a marker for cancer, cardiovascular diseases, diabetes mellitus, and metabolic syndrome. Here, CLU is linked to cardiovascular disorder.